Pyridoxine Prophylaxis with Isoniazid
Pyridoxine (vitamin B6) 25-50 mg daily should be prescribed prophylactically to all patients on isoniazid who have risk factors for peripheral neuropathy, including pregnant women, breastfeeding infants, persons with HIV, and patients with diabetes, alcoholism, malnutrition, chronic renal failure, or advanced age 1, 2.
Who Requires Prophylactic Pyridoxine
The most recent ATS/CDC/ERS/IDSA guidelines (2016) provide clear criteria for prophylactic supplementation 1, 2:
High-risk populations requiring supplementation:
- Pregnant women
- Breastfeeding infants
- Persons infected with HIV
- Patients with diabetes mellitus
- Patients with alcoholism
- Malnourished patients
- Patients with chronic renal failure
- Patients of advanced age
The mechanism is straightforward: isoniazid competitively inhibits pyridoxine's metabolic functions, particularly affecting protein, carbohydrate, and fatty acid metabolism, as well as brain amine synthesis 3. This interference can lead to peripheral neuropathy, which occurs predominantly in slow inactivators of isoniazid 4.
Recommended Dosing
Standard prophylactic dose: 25-50 mg daily 1, 2
For established peripheral neuropathy: Increase to 100 mg daily 1
This dosing is remarkably cost-effective and has been validated across multiple studies. Historical research from the Tuberculosis Chemotherapy Centre in Madras demonstrated that even 6 mg daily was fully effective in preventing peripheral neuropathy with high-dose isoniazid (12.5-15.6 mg/kg) 5. The current recommendation of 25-50 mg provides an additional safety margin.
Special Populations
Pregnant patients: The 2003 ATS guidelines specifically note that pyridoxine supplementation (25 mg/day) is recommended during pregnancy, as the risk of hepatitis may be increased in the peripartum period 6. A 1982 study confirmed that 50-60 mg daily produces adequate pyridoxal phosphate concentrations in pregnant patients receiving isoniazid 7.
Children: This is where guidelines diverge from common practice. While older teaching suggested pyridoxine deficiency was rare in children, a 1985 study found 13% of children on isoniazid developed deficiency, particularly those receiving >10 mg/kg/day 8. However, a 1998 placebo-controlled study in 85 children found no neurological complications without supplementation 9. The 2012 guideline for drug-resistant TB in children recommends pyridoxine for peripheral neuropathy management but doesn't mandate universal prophylaxis 10.
Practical approach for children: Consider prophylaxis for those with malnutrition, HIV infection, or receiving high-dose isoniazid (>10 mg/kg/day), even though routine supplementation may not be necessary for well-nourished children on standard doses.
Other Vitamin B6-Depleting Medications
Beyond isoniazid, the 2022 ESPEN micronutrient guideline identifies additional medications requiring consideration 11:
- Linezolid (used in drug-resistant TB)
- Cycloserine/terizidone (second-line TB drugs)
- Penicillamine
- Anticonvulsants
- Corticosteroids
- Certain chemotherapy agents
For these medications, the same risk-based approach applies: supplement patients with baseline risk factors for neuropathy.
Monitoring and Safety
What to monitor: Plasma pyridoxal phosphate (PLP) levels are the gold standard. In seriously ill patients or those with inflammation, red cell PLP should be measured instead, as inflammation artificially lowers plasma levels 11.
Common pitfall: Do not assume multivitamin preparations provide adequate supplementation. Most contain <25 mg pyridoxine, which may be insufficient 6.
Toxicity threshold: Long-term doses >100 mg/day have been associated with sensory neuropathy (Lhermitte signs), though the no-observed-adverse-effect level is 100 mg/day 11. Doses >500 mg/day carry significant risk. Interestingly, high-dose pyridoxine (the inactive form) can paradoxically cause vitamin B6 deficiency symptoms by competitively inhibiting active pyridoxal-5'-phosphate 12.
Emergency Dosing
Isoniazid overdose with seizures: 1 gram pyridoxine IV for each gram of isoniazid ingested, up to 5 grams total in adults or 80 mg/kg in children 11, 13. This is a critical, life-saving intervention that should be administered rapidly over 3-5 minutes 13.
The evidence strongly supports routine prophylactic supplementation for at-risk populations, with the 25-50 mg daily dose representing an optimal balance of efficacy, safety, and cost-effectiveness.